News about Biotechnology

Freudenberg Expands Bioprocessing Capabilities at CPHI and PMEC India

Freudenberg Expands Bioprocessing Capabilities at CPHI and PMEC India

The global manufacturer has introduced its CleanAssure system, a cleanroom-based sanitary washing and drying workstation that uses ultra-purified water and filtered air to enhance safety for single-use tubings and assemblies.

Biotechnology | 25/11/2025 | By Darshana

India Unveils its First Indigenous CRISPR-based Gene Therapy 'BIRSA 101' for Sickle Cell Disease

India Unveils its First Indigenous CRISPR-based Gene Therapy 'BIRSA 101' for Sickle Cell Disease

India has formally begun its decisive journey towards becoming a Sickle Cell Disease–free nation, with Union Minister of State for Science & Technology Dr. Jitendra Singh launching the country's first indigenous CRISPR-based gene therapy for the condition.

Biotechnology | 20/11/2025 | By Dineshwori 224

EirGenix Signs Second Global Licensing Deal With Sandoz for Pertuzumab Biosimilar

EirGenix Signs Second Global Licensing Deal With Sandoz for Pertuzumab Biosimilar

EirGenix Inc., a Taiwan-based biopharmaceutical and CDMO company, has signed a second global exclusive licensing agreement with Sandoz AG for the commercialization of its pertuzumab biosimilar EG1206A, developed as an alternative to Roche’s Perjeta.

Biotechnology | 14/11/2025 | By Darshana 104

Dyadic International Partners with Intralink to Strengthen Biotech Footprint in Japan and South Korea

Dyadic International Partners with Intralink to Strengthen Biotech Footprint in Japan and South Korea

Dyadic International, Inc. (operating as Dyadic Applied BioSolutions), a US-based biotechnology innovator, has appointed international business development consultancy Intralink to expand its commercial presence in Japan and South Korea — two of Asia’s fastest-growing and most advanced biopharmaceutical markets.

Biotechnology | 10/11/2025 | By Darshana 111

Bharat Biotech Launches Nucelion, a New CRDMO Focused on Cell and Gene Therapies

Bharat Biotech Launches Nucelion, a New CRDMO Focused on Cell and Gene Therapies

The new entity, based in Genome Valley, Hyderabad, is designed to partner with global life-science innovators to deliver end-to-end solutions for complex biologic medicines.

Biotechnology | 03/11/2025 | By Darshana 260

FDA Grants Tentative Approval to Amneal Pharmaceuticals' Generic Version of QVAR Inhalation Aerosol

FDA Grants Tentative Approval to Amneal Pharmaceuticals' Generic Version of QVAR Inhalation Aerosol

Beclomethasone dipropionate HFA inhalation aerosol is a corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in patients aged five years and older. It is not indicated for the relief of acute bronchospasm.

Biotechnology | 31/10/2025 | By Darshana 117

Medinet Japan partners with India's Stempeutics for Stempeucel cell therapy to treat CLTI

Medinet Japan partners with India's Stempeutics for Stempeucel cell therapy to treat CLTI

Medinet Co., Ltd, a Tokyo-listed regenerative medicine and CDMO company, has signed an option licence agreement with India-based Stempeutics Research for the development and commercialisation of its Stempeucel therapy in Japan, targeting Chronic Limb Threatening Ischaemia (CLTI).

Biotechnology | 29/10/2025 | By Darshana 160

DPIIT and Thermo Fisher Scientific Sign MoU to Strengthen India's Biotech Startup Ecosystem

DPIIT and Thermo Fisher Scientific Sign MoU to Strengthen India's Biotech Startup Ecosystem

The partnership between DPIIT and Thermo Fisher Scientific to support 500+ biotech startups through advisory, mentorship and nationwide challenge.

Biotechnology | 04/10/2025 | By Dineshwori 174

Alkem Launches Pertuzumab Biosimilar Pertuza in India for HER2-Positive Breast Cancer

Alkem Launches Pertuzumab Biosimilar Pertuza in India for HER2-Positive Breast Cancer

Alkem Laboratories has introduced Pertuza, a biosimilar of pertuzumab, in India for the treatment of HER2-positive breast cancer. The drug is supplied as a 420 mg/14 mL injection and is developed and manufactured domestically.

Biotechnology | 23/09/2025 | By Darshana 234

Abzena Enhances AbZelectPRO Cell Line Offering with New GS Knockout Platforms

Abzena Enhances AbZelectPRO Cell Line Offering with New GS Knockout Platforms

Named AbZelectPRO-KO and AbZelectPRO-KO+, the new GS knockout platforms are available as a stand-alone CLD offering, or as a fully integrated GMP programme, with fully transparent pricing to IND with no royalty fees. This flexible offering will enable customers to select a CLD strategy that aligns with their project-specific goals, timeline and budget.

Biotechnology | 15/09/2025 | By Dineshwori 168

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members